
Sterile RTU Glass Vials
- Type I borosilicate, ISO 8362 compliant
- 2R · 6R · 10R · 20R formats
- RTU sterile, depyrogenated
- EU blowback geometry compatible
- Injectable & lyophilisation applications

LBS International supplies sterile ready-to-use primary packaging components for pharmaceutical and biotech manufacturing environments worldwide.
Eight pillars that define our approach to supplying primary packaging into regulated pharmaceutical and biotech manufacturing environments.
Tub & nest components washed, depyrogenated and sterilised by qualified manufacturing partners — ready for direct introduction to aseptic filling.
Pharmaceutical-grade glass evaluated against USP <660> and EP 3.2.1 for chemical resistance and injectable suitability.
Lyo-slot stopper geometries and matched vial formats engineered for stable freeze-drying cycles and reliable closure integrity.
Documentation packages aligned to internal qualification protocols — supporting evaluation, sampling and validation activities.
Dual-sourcing strategies, buffer stock programmes and project-aligned delivery scheduling for commercial fill-finish operations.
Fluoropolymer-coated bromobutyl elastomers and controlled cleanroom packaging to minimise sub-visible particulate contribution.
Components produced in accordance with ISO 8362 vial dimensional standards for compatibility with standard filling platforms.
End-to-end lot-level genealogy from manufacturing partner batch through GDP-controlled distribution to customer site.
Three core component families engineered to integrate cleanly on standard pharmaceutical filling and lyophilisation platforms.



LBS International operates as a GDP-controlled distribution partner. All manufacturing, sterilisation, depyrogenation and RTU processing are performed by qualified manufacturing partners operating under ISO 15378 / ISO 9001 quality systems.
Primary packaging materials manufactured under recognised pharma standard.
Quality management systems applied across the supply chain.
Materials evaluated against USP <660>, <381>, EP 3.2.1 / 3.2.9.
Washed, depyrogenated, sterilised — ready for aseptic filling.
Drug Master File coverage available for regulatory submissions.
Good Distribution Practice principles across European logistics.
Formal change notification protocols with end customers.
Lot-level batch traceability across the controlled supply chain.
"Components are manufactured in accordance with applicable ISO vial and stopper dimensional standards and are intended for evaluation and qualification on standard pharmaceutical filling and lyophilisation equipment platforms."
From early development to commercial-scale fill-finish, LBS International acts as a technical packaging partner — closing supply gaps, mitigating shortages and supporting qualification activities on aseptic filling and lyophilisation lines.

We work alongside pharmaceutical and biotech quality teams from initial supplier assessment through to ongoing supply, aligning documentation and protocols to internal qualification frameworks.
Read the qualification frameworkProducts are supplied for customer-specific technical evaluation, qualification and validation activities. Final suitability for commercial use remains subject to customer qualification and GMP validation requirements.